framingham study
Recently Published Documents


TOTAL DOCUMENTS

462
(FIVE YEARS 21)

H-INDEX

121
(FIVE YEARS 3)

2021 ◽  
Vol 17 (S5) ◽  
Author(s):  
Rachel F. Buckley ◽  
Adrienne O’Donnell ◽  
Emer R. McGrath ◽  
Heidi I.L. Jacobs ◽  
Claudia L. Satizabal ◽  
...  

2020 ◽  
Vol 81 ◽  
pp. 95-96
Author(s):  
Marco Zuin ◽  
Claudio Bilato ◽  
Giovanni Zuliani ◽  
Loris Roncon

PLoS ONE ◽  
2020 ◽  
Vol 15 (5) ◽  
pp. e0233321
Author(s):  
Cecilia Castro-Diehl ◽  
Rebecca J. Song ◽  
Gary F. Mitchell ◽  
David McManus ◽  
Susan Cheng ◽  
...  

2020 ◽  
Vol 32 (3) ◽  
pp. 200-208
Author(s):  
José Tarcísio Medeiros Vasconcelos ◽  
Carlos Eduardo Duarte ◽  
Silas dos Santos Galvão Filho

The correlation between atrial fibrillation (AF) and thromboembolism is well known. In 1951, Raymond Daley et al. associated the occurrence of this arrhythmia to systemic embolic events with consistent information in patients with chronic rheumatic heart disease1. In this study involving 194 patients with rheumatic heart disease who were victims of thromboembolism, with autopsy information in 39 patients, the presence of AF was demonstrated in about 90% of cases. The classic Framingham study, published in 1978, was the first large study that established this same correlation in nonrheumatic individuals, showing that individuals with AF are nearly six times more likely to have a stroke than the AF-free individuals with characteristics adjusted for sex, age and blood pressure2. The inclusion of rheumatic individuals has raised this risk to approximately 18 times. Since this important publication, several studies have corroborated these findings.


2019 ◽  
Vol 30 (9) ◽  
pp. 1897-1897
Author(s):  
A.B. Dufour ◽  
B. Roberts ◽  
K.E. Broe ◽  
D.P. Kiel ◽  
M.L. Bouxsein ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document